Document is current
Any future updates will be listed below
-
Authors
Lamming, Dudley W. https://orcid.org/0000-0002-0079-4467
-
Funding
Funding for this research was provided by:
National Institute on Aging (AG056771, AG062328, AG081482, AG084156)
National Institute of Diabetes and Digestive and Kidney Diseases (DK125859)
- License Information
-
More Information
Article History
Received: 24 April 2024
Accepted: 8 May 2024
First Online: 17 May 2024
Declarations
:
: DWL has received funding from, and is a scientific advisory board member of, Aeovian Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases.
: The content is solely the responsibility of the author and does not necessarily represent the official views of the NIH.
